Differential expression of glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types

Journal of Chemotherapy

Volumn 20, Issue 1, 2008, Pages 106-111

  Subbarayan, Pochi R ^a   Wang, P G ^b   Lampidis, T J ^a   Ardalan, B ^a   Braunschweiger, P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Glucose; Glucose transport; SNAP and Real Time PCR; Transport

Indexed keywords

GLUCOSE TRANSPORTER 1; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MITOCHONDRION; OSTEOBLASTOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 41149149805     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.1.106     Document Type: Article

References (26)

1. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61(6):866-879.
2. Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991; 261(4 Pt 2):H1043-H1052.
3. Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 1996; 97(11):2562-2568.
4. Hibbs JB, Jr., Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235(4787):473-476.
5. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61(6):866-879.
6. Hibbs JB, Jr., Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235(4787):473-476.
7. Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol 1995; 196:57-73.
8. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87(4):1620-1624.
9. Liu J, Li C, Qu W, Leslie E, Bonifant CL, Buzard GS, et al. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol Cancer Ther 2004; 3(6):709-714.
10. Azizzadeh B, Yip HT, Blackwell KE, Horvath S, Calcaterra TC, Buga GM, et al. Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 2001; 111(11 Pt 1):1896-1900.
11. Kurimoto M, Endo S, Hirashima Y, Hamada H, Ogiichi T, Takaku A. Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J Neurooncol 1999; 42(1):35-44.
12. Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, et al. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer 2000; 88(2):381-388.
13. Hawkins RA, Hoh C, Dahlbom M, Choi Y, Glaspy J, Tse N, et al. PET cancer evaluations with FDG. J Nucl Med 1991; 32(8):1555-1558.
14. Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJ. Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry 2001; 40(18):5542-5547.
15. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S. Molecular biology of mammalian glucose transporters. Diabetes Care 1990; 13(3):198-208.
16. Boado RJ, Pardridge WM. Measurement of blood-brain barrier GLUT1 glucose transporter and actin mRNA by a quantitative polymerase chain reaction assay. J Neurochem 1994; 62(6):2085-2090.
17. Stein GH. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 1979; 99(1):43-54.
18. Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, Wang P, Penalver M, Averette H, Braunschweiger P. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer 2000; 88(2):381-388.
19. Braunschweiger PG, Basrur VS, Cameron D, Sharpe L, Santos O, Perras JP, et al. Modulation of cisPlatin cytotoxicity by interleukin-1 alpha and resident tumor macrophages. Biotherapy 1997; 10(2):129-137.
20. Chakrabarti R, Jung CY, Lee TP, Liu H, Mookerjee BK. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 1994; 152(6):2660-2668.
21. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002; 32(6):1372-1379.
22. Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y, Endo K. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 2006; 97(12):1291-1297.
23. Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul 1996; 34:159-187.
24. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A 1985; 82(18):6133-6137.
25. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, et al. Sequence and structure of a human glucose transporter. Science 1985; 229(4717):941-945.
26. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002; 32(6):1372-1379.